|27.36||-0.1700||-0.62%||Vol 311.90K||1Y Perf 131.15%|
|Apr 19th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||26.33||Analyst Rating||Hold 2.90|
|Potential %||-3.76||Finscreener Ranking||☆ 31.83|
|Insiders Trans % 3/6/12 mo.||-/-/100||Value Ranking||☆ 31.94|
|Insiders Value % 3/6/12 mo.||-/-/100||Growth Ranking||★ 29.96|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/100||Income Ranking||★ 30.73|
|Market Cap||1.27B||Earnings Rating||Sell|
|Price Range Ratio 52W %||52.84||Earnings Date||21st Apr 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||21st Apr 2021|
|Estimated EPS Next Report||0.13|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||315.08K|
|Avg. Monthly Volume||353.91K|
|Avg. Quarterly Volume||466.05K|
Core Laboratories N.V. (NYSE: CLB) stock closed at 27.36 per share at the end of the most recent trading day (a -0.62% change compared to the prior day closing price) with a volume of 312.09K shares and market capitalization of 1.27B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Oil & Gas industry, Energy sector and employs 3700 people. Core Laboratories N.V. CEO is Lawrence Bruno.
The one-year performance of Core Laboratories N.V. stock is 131.15%, while year-to-date (YTD) performance is 3.21%. CLB stock has a five-year performance of -76.75%. Its 52-week range is between 10.97 and 41.99, which gives CLB stock a 52-week price range ratio of 52.84%
Core Laboratories N.V. currently has a PE ratio of -12.50, a price-to-book (PB) ratio of 17.80, a price-to-sale (PS) ratio of 3.78, a price to cashflow ratio of 21.20, a PEG ratio of 2.32, a ROA of -13.83%, a ROC of -18.65% and a ROE of -73.64%. The company’s profit margin is 7.08%, its EBITDA margin is -11.50%, and its revenue ttm is $334.87 Million , which makes it $7.24 revenue per share.
Of the last four earnings reports from Core Laboratories N.V., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.13 for the next earnings report. Core Laboratories N.V.’s next earnings report date is 21st Apr 2021.
The consensus rating of Wall Street analysts for Core Laboratories N.V. is Hold (2.9), with a target price of $26.33, which is -3.76% compared to the current price. The earnings rating for Core Laboratories N.V. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Core Laboratories N.V. has a dividend yield of 0.15% with a dividend per share of $0.04 and a payout ratio of 104.00%.
Core Laboratories N.V. has a Sell technical analysis rating based on Technical Indicators (ADX : 8.68, ATR14 : 2.02, CCI20 : -89.14, Chaikin Money Flow : -0.16, MACD : -1.75, Money Flow Index : 34.24, ROC : -4.97, RSI : 59.75, STOCH (14,3) : 28.22, STOCH RSI : 0.05, UO : 41.63, Williams %R : -71.78), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Core Laboratories N.V. in the last 12-months were: Gregory B. Barnett (Option Excercise at a value of $0), Harvey Klingensmith (Option Excercise at a value of $0), Jan Willem Sodderland (Buy at a value of $20 484), Kevin Daniels (Option Excercise at a value of $0), Margaret Ann van Kempen (Option Excercise at a value of $0), Martha Z. Carnes (Option Excercise at a value of $0), Michael Straughen (Option Excercise at a value of $0), Monique van Dijken Eeuwijk (Option Excercise at a value of $0)
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.